Catalyst Wire Dossier Catalyst Wire Dossier

Tumor Infiltrating Lymphocytes (TIL) Adjuvant Therapy

tumor-infiltrating lymphocytes · Nantes University Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tumor Infiltrating Lymphocytes (TIL) Adjuvant Therapy, covering 2017-06-01 to 2017-06-01. Get the full timeline:

Most recent: Clinical Trial Update: Tumor Infiltrating Lymphocytes Adjuvant Therapy of Melanoma [Phase 3]

See pricing